The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Evaluation of Functionally Meaningful Measures for Clinical Trials of Cognition Enhancement in Schizophrenia
Abstract
OBJECTIVE: Because reduction of psychotic symptoms in schizophrenia does not result in adequate community functioning, efforts have shifted to other areas, such as cognitive impairment. The U.S. Food and Drug Administration requires that drugs for cognition enhancement in schizophrenia show improvement on two distinct outcome measures in clinical trials: an accepted cognitive performance battery and a functionally meaningful coprimary measure. The authors examined the reliability, validity, and practicality of functionally meaningful measures. METHOD: In this four-site validation study, schizophrenia patients were assessed at baseline (N=166) and 4 weeks later (N=144) on performance-based (Independent Living Scales, Test of Adaptive Behavior in Schizophrenia [TABS], and UCSD Performance-based Skills Assessment [UPSA]) and interview-based (Cognitive Assessment Interview and Clinical Global Impression Scale for Cognition) candidate coprimary measures. In addition, cognitive performance, community functioning, and clinical symptoms were assessed. Both full and short forms of the performance-based measures were evaluated. RESULTS: All measures were well tolerated by patients, had adequate test-retest reliability, and showed good utility as a repeated measure. Measures differed in their correlation with cognitive performance, with performance-based measures having stronger correlations than interview-based measures. None of the measures had notable floor or ceiling effects or missing data. CONCLUSIONS: Among the full-form measures, the UPSA was judged to have the strongest overall properties. Among the short forms, the TABS and UPSA appeared to have the strongest features. Use of the short forms saves time, but at the cost of lower test-retest reliability and weaker correlations with cognitive performance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, the reliability, validity, and practicality of functionally meaningful co-primary measures was established,68 and the MCCB impairment profile for schizophrenia outpatients became available.69”
From Clinical trials of potential cognitive-enhancing drugs in schizophrenia: what have we learned so far? (2013) · cites this paper as [68]
In the citing paper
“The recent VIM study68 suggests that there are no optimal co-primary measures, although several of them have reasonable psychometric characteristics.”
From Clinical trials of potential cognitive-enhancing drugs in schizophrenia: what have we learned so far? (2013) · cites this paper as [68]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
(2012) · Springer eBooks · doi:10.1007/springerreference_121117 · Cited by 20,772
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity
Nuechterlein, K. H., Green, M. F., Kern, R. S., Baade, L. E., Barch, D. M., Cohen, J. D., Essock, S., Fenton, W. S., Frese, F. J., Gold, J. M., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07010042 · Cited by 2,342
(2001) · Defense Technical Information Center (DTIC) · Cited by 2,158
The Quality of Life Scale: An Instrument for Rating the Schizophrenic Deficit Syndrome
Heinrichs, D. W., Hanlon, T. E., & Carpenter, W. T. (1984) · Schizophrenia Bulletin · doi:10.1093/schbul/10.3.388 · Cited by 1,693
The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation
Kay, S. R., Opler, L. A., & Lindenmayer, J.-P. (1989) · British Journal of Psychiatry · doi:10.1192/s0007125000291514 · Cited by 1,016
Green, M. F., Nuechterlein, K. H., Gold, J. M., Barch, D. M., Cohen, J., Essock, S., Fenton, W. S., Frese, F., Goldberg, T. E., Heaton, R. K., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.023 · Cited by 919
The Effects of Risperidone on the Five Dimensions of Schizophrenia Derived by Factor Analysis
Marder, S. R., Davis, J. M., & Chouinard, G. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n1205 · Cited by 761
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization
Kern, R. S., Nuechterlein, K. H., Green, M. F., Baade, L. E., Fenton, W. S., Gold, J. M., Keefe, R. S. E., Mesholam-Gately, R., Mintz, J., Seidman, L. J., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07010043 · Cited by 744
Patterson, T., Goldman, S., McKibbin, C. L., Hughs, T., & Jeste, D. V. (2001) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006870 · Cited by 740
Buchanan, R. W. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi020 · Cited by 438
Flagged first, then by citations
Research works printed but not linked: 5
- Nuechterlein KH, 2006, MATRICS Consensus Cognitive Battery
- 10.1037/0021-843X.103.2.371 · DOI
- Loeb PA, 1996, Independent Living Scales Manual
- Reise SP, Psychol Assess
- Kern RS, Schizophr Res
Cited by
Sorted by citations
Items 101–159 of 159
Flores, A. T., Hogarty, S. S., Mesholam‐Gately, R. I., Barrio, C., Keshavan, M. S., & Eack, S. M. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.05.016 · Cited by 11
Vaz, S. M., Heinrichs, R. W., Miles, A. A., Ammari, N., Archie, S., Muharib, E., & Goldberg, J. O. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.10.020 · Cited by 11
Kurtz, M. M., Donato, J., & Rose, J. S. (2011) · Neuropsychology · doi:10.1037/a0025534 · Cited by 11
McGovern, J. E., Reddy, L. F., Reavis, E. A., & Green, M. F. (2020) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2020.05.003 · Cited by 11
Citrome, L., Mychaskiw, M. A., Cortez, A., Opler, M. G. A., Sopina, L., & Kotak, S. V. (2023) · PubMed Central · Cited by 10
Jacobson, W., Zhong, W., Nomikos, G. G., Christensen, M. C., Olsen, C. K., & Harvey, P. D. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1657692 · Cited by 10
Campbell, E. A., Olagunju, A. T., Aina, O. F., & Ogbolu, R. E. (2015) · Journal of Psychosocial Rehabilitation and Mental Health · doi:10.1007/s40737-015-0025-6 · Cited by 9
Christensen, M. C., Sluth, L. B., & McIntyre, R. S. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.11.034 · Cited by 9
Horan, W. P., Depp, C. A., Hurst, S., Linthicum, J., Vargas, G. S., Klein, H., Keefe, R. S. E., & Harvey, P. D. (2023) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgad012 · Cited by 8
Triptish Bhatia, A., Kumari, N., Yadav, A., Beniwal, R. P., Shah, G., Joel, W., Jones, J. R., Iyenger, S., Nimgaonkar, V. L., & Deshpande, S. N. (2022) · Acta Neuropsychiatrica · doi:10.1017/neu.2022.14 · Cited by 9
Szabo, S. M., Merikle, E. P., Lozano‐Ortega, G., Powell, L., Macek, T. A., & Cline, S. K. (2018) · Schizophrenia Research and Treatment · doi:10.1155/2018/9075174 · Cited by 8
Effectiveness of fast mapping to promote learning in schizophrenia
Korenic, S. A., Nisonger, S. J., Krause, B. W., Wijtenburg, S. A., Hong, L. E., & Rowland, L. M. (2016) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2016.04.003 · Cited by 8
Maciver, D., Morley, M., Forsyth, K., Bertram, N., Edwards, T., Heasman, D., Rennison, J., Rush, R., & Willis, S. (2015) · British Journal of Occupational Therapy · doi:10.1177/0308022615591173 · Cited by 8
Randers, L., Fagerlund, B., Jepsen, J. R. M., Nordholm, D., Krakauer, K., Hjorthøj, C. R., Glenthoj, B. Y., & Nordentoft, M. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113498 · Cited by 8
Diagnostic digital phenotyping in schizophrenia-spectrum disorders: a systematic review
Vecchio, I., Mifsud, L., Almeida, S. C. E., & Passecker, J. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-02194-w · Cited by 7
Engel, L., Chui, A., Beaton, D., Green, R., & DAWSON, D. R. (2018) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2018.02.004 · Cited by 6
Miller, B. J., Pikalov, A., SIU, C. O., Tocco, M., Tsai, J., Harvey, P. D., Newcomer, J. W., & Loebel, A. D. (2020) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2020.152195 · Cited by 6
Tcheremissine, O. V., Castro, M. A., & Gardner, D. R. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.634798 · Cited by 6
Cuesta, M. J., Sánchez-Torres, A. M., Lorente-Omeñaca, R., Zandio, M., Moreno-Izco, L., & Peralta, V. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113404 · Cited by 6
Development of a Virtual Reality Assessment of Everyday Living Skills
Ruse, S. A., Davis, V. G., Atkins, A. S., Krishnan, K. R. R., Fox, K. H., Harvey, P. D., & Keefe, R. S. E. (2014) · Journal of Visualized Experiments · doi:10.3791/51405-v · Cited by 6
Functional implications and course
Harvey, P. D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003872.006 · Cited by 6
Bismark, A. W., Mikhael, T., Mitchell, K. R., Holden, J. L., & Granholm, E. L. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.03.025 · Cited by 5
Guzman, A., Klein, H., Keefe, R. S. E., Horan, W. P., & Harvey, P. D. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116121 · Cited by 5
Pezzella, P., Caporusso, E., Mucci, A., Bucci, P., Giordano, G. M., Amore, M., Rocca, P., Rossi, A., Bertolino, A., Ventura, J., et al. (2024) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgae020 · Cited by 5
Harris, A. W. F., Kightley, M., Williams, J. G., Ma, C., & Dodds, C. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.789628 · Cited by 4
Validation of the Chinese Version of the Schizophrenia Cognition Rating Scale
Huang, K.-W., Lin, P., Lee, Y., Huang, Y., Hung, C., Lee, S.-Y., Chen, C., & Wang, L. (2022) · Psychiatry Investigation · doi:10.30773/pi.2021.0322 · Cited by 4
Tan, Y., Zong, X., Li, H., Feng, M., He, J., Sun, X., Zhang, Y., Wang, X., Yao, J. J., & Hu, M. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1675079 · Cited by 3
Stress and Mental Flexibility in Autism Spectrum Disorders
Stone, W. S., & Iguchi, L. (2013) · North American Journal of Medicine and Science · Cited by 3
Keefe, R. S. E., Nomikos, G. G., Zhong, W., Christensen, M. C., & Jacobson, W. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy020 · Cited by 4
Pharmacological approaches to cognitive enhancement
Harvey, P. D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003872.016 · Cited by 2
Clinical Instruments to Evaluate and Guide Treatment in Schizophrenia
Marder, S. R. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25758-2_1 · Cited by 2
Lobos, C. A., Marcelo Arancibia, M., Cortés-Jofré, M., Huang, T., Li, T., Eva Madrid, A., & Leucht, S. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.116956 · Cited by 1
Cognition and functional status in adult and older patients with schizophrenia
Czaja, S. J., & Loewenstein, D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003872.008 · Cited by 1
Integrierte Neurokognitive Therapie (INT) bei Schizophrenie
Müller, D. (2012) · Psychiatrie und Psychotherapie up2date · doi:10.1055/s-0032-1305080 · Cited by 1
Validation of a Video Based Scale for Measuring Social Cognition in Schizophrenia
Lee, J. S., Kim, H., Chon, M., Ahn, J.-H., Joo, Y. H., & Kim, C.-Y. (2016) · 신경정신의학 · doi:10.4306/jknpa.2016.55.2.122 · Cited by 1
Schmidt, S. J., & Roder, V. (2015) · Springer eBooks · doi:10.1007/978-3-319-13245-7_1 · Cited by 1
Genetics of bipolar disorder and schizophrenia
Bigdeli, T. B., & Harvey, P. D. (2022) · Oxford University Press eBooks · doi:10.1093/med/9780197574522.003.0013 · Cited by 1
Prichard, T. M., Roiboit, C. M., Rankin, M., Glikmann‐Johnston, Y., Gordon, M. F., & Stout, J. C. (2025) · Journal of Huntington s Disease · doi:10.1177/18796397251330846 · Cited by 1
Role of cognitive enhancement in schizophrenia
Galletly, C. A. (2014) · Neuroscience and Neuroeconomics · doi:10.2147/nan.s38865 · Cited by 1
Makarewicz, A., Karakuła‐Juchnowicz, H., & Łobejko, Ł. (2017) · Current Problems of Psychiatry · doi:10.1515/cpp-2017-0005 · Cited by 1
Assessment of social cognition
Silberstein, J., & Harvey, P. D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815315-4.00009-4 · Cited by 1
Functional Outcomes Assessment Scales
Harvey, P. D. (2012) · doi:10.1007/978-1-908517-71-5_4 · Cited by 1
Schizophrenia Spectrum Conditions
Harvey, P. D., & Bowie, C. R. (2012) · Handbook of Psychology, Second Edition · doi:10.1002/9781118133880.hop208010 · Cited by 1
Stone, W. S., & Hsi, X. (2011) · Chinese Science Bulletin · doi:10.1007/s11434-011-4759-6 · Cited by 1
Performance-based measures of functioning in schizophrenia
Depp, C. A., de Dios, L. V., Mausbach, B. T., & Patterson, T. L. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003872.015
Assessment and treatment of cognitive impairment and related features
Harvey, P. D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003872.014
Estrés Oxidativo y Esquizofrenia
Prados, A. B. (2014) · Gredos (University of Salamanca) · doi:10.14201/gredos.124073
Innovación educativa en las redes sociales online: un estudio en la educación superior
González, J. G. (2015) · UPM Digital Archive (Technical University of Madrid) · doi:10.20868/upm.thesis.39598
Harvey, P. D., & Keefe, R. S. E. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977640.013
Mental Health Retrosight: Perspectives
Pollitt, A., Diepeveen, S., Guthrie, S., Horvitz-Lennon, M. V., Jones, M. M., Chonaill, S. N., Schultz, D. J., Pincus, H. A., Grant, J., & Wooding, S. (2013) · RAND Corporation eBooks · doi:10.7249/rr451
Schmidt, S. J., & Roder, V. (2015) · Springer eBooks · doi:10.1007/978-88-470-5735-7_1
Roder, V., & Schmidt, S. J. (2013) · Springer eBooks · doi:10.1007/978-3-642-21440-0_1
PADRÕES DE ATIVIDADES INSTRUMENTAIS DA VIDA DIÁRIA ENTRE IDOSOS DA COMUNIDADE
Sigrist, A. D. A. F. (2021) · doi:10.17771/pucrio.acad.53089
Kraus, M., & Keefe, R. S. E. (2012) · doi:10.1007/978-1-908517-71-5_3
(2012) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.10.2.186
Evolving Concepts for the Assessment and Treatment of Schizophrenia
Giordano, G. M., Pezzella, P., Gäebel, W., & Galderisi, S. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009067287.015
Pharmacological Treatment of Cognitive Impairment in Schizophrenia
Neff, M. A., & Harvey, P. D. (2025) · Comprehensive approach to psychiatry · doi:10.1007/978-3-032-06209-3_12
Silverman, I. H., Kaur, D., Campbell, L. M., Mahmood, Z., Keller, A. V., & Twamley, E. W. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117386
Harvey, P. D., Schooler, N. R., & Ahmed, A. O. (2026) · Schizophrenia Bulletin · doi:10.1093/schbul/sbag121
Metadata
- Authors
- Green, M. F., Schooler, N. R., Kern, R. S., Frese, F. J., Granberry, W., Harvey, P. D., Karson, C. N., Peters, N., Stewart, M., Seidman, L. J., Sonnenberg, J., Stone, W. S., Walling, D., Stover, E., & Marder, S. R.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Green, Michael F.
- ORCID
- Venue
- American Journal of Psychiatry
- Published
- 2011-04
- Volume
- 168
- Issue
- 4
- Pages
- 400-407
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2151080668
- Cited by
- 159
- References
- 23
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 5 · 2023: 3 · 2022: 11 · 2021: 3 · 2020: 7 · 2019: 8 · 2018: 13 · 2017: 6 · 2016: 12 · 2015: 18 · 2014: 12 · 2013: 18 · 2012: 23
- FWCI
- 14.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (HHSN278 200441003C)
- National Institute of Mental Health (MH042392)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- schizophrenia, cognitive enhancement, community functioning, test-retest reliability, performance-based measures, cognitive impairment
- MeSH terms
- Activities of Daily Living, Adult, Clinical Trials as Topic, Cognition, Female, Humans, Interviews as Topic, Male, Neuropsychological Tests, Psychometrics, Quality of Life, Schizophrenia, Schizophrenic Psychology, Reproducibility of Results, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review